Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection
Su-Jun Zheng1, Feng Qu2, Jun-Feng Li3
1Artificial Liver Center, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Insights
Serum sphingolipids are linked to liver injury in chronic hepatitis B virus (HBV) infection. Specific sphingomyelin (SM) compounds, like SM(d18:1/24:0), may serve as biomarkers for hepatic injury and cirrhosis.
Area of Science:
- Biochemistry
- Hepatology
- Biomarker Discovery
Background:
- Chronic hepatitis B virus (HBV) infection is a significant global health concern.
- Hepatic injury and cirrhosis are serious complications of chronic HBV infection.
- Understanding the molecular mechanisms underlying liver damage in HBV is crucial for developing new diagnostic tools.
Purpose of the Study:
- To investigate the association between serum sphingolipid profiles and the severity of hepatic injury in patients with chronic HBV infection.
- To identify potential serum biomarkers for liver damage and cirrhosis in the context of chronic HBV.
Main Methods:
- Serum samples from healthy individuals and patients with chronic HBV infection (including chronic hepatitis B and HBV-related cirrhosis) were analyzed.
- High-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) was employed to quantify serum sphingolipids.
- Liver biopsy data and clinical indicators, such as the Model for End-Stage Liver Disease (MELD) score, were correlated with sphingolipid levels.
Main Results:
- Eighteen out of twenty-four detected serum sphingolipids showed significant differences between healthy controls and chronic HBV-infected individuals.
- Fourteen sphingolipids were significantly different between chronic hepatitis B and HBV-related cirrhosis groups.
- Sphingomyelin (SM) compound SM(d18:1/24:0) demonstrated a negative correlation with MELD score and was associated with inflammation grades in liver biopsies.
Conclusions:
- Serum sphingolipids are closely related to hepatic injury in chronic HBV infection.
- SM(d18:1/24:0) shows potential as a non-invasive serum biomarker for assessing liver damage and disease progression in chronic HBV patients.
Objective:
To explore the relation between serum sphingolipids and hepatic injury in chronic HBV infection.
Methods:
A cohort of participants including 48 healthy persons, 103 chronic HBV-infected patients containing chronic hepatitis B (CHB) and HBV-related cirrhosis were included. High performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) was performed to detect serum sphingolipids. The serological indicators were detected and quantified. The valid liver biopsy specimens were acquired from twenty five CHB.
Results:
Twenty four serum sphingolipids were detected. There were eighteen sphingolipids showing significant differences between the healthy control and chronic HBV infection groups. In patients with chronic HBV infection, fourteen sphingolipids differed significantly between CHB and HBV-related cirrhosis. Among sphingolipids with a significant difference in both HBV infection vs healthy control and CHB vs cirrhosis, seven sphingolipids were independently related to the presence of cirrhosis. SM(d18:1/24:0), a sphingomyelin (SM) compound, was found to have a negative correlation with model for end-stage liver disease (MELD) score. Additionally, SM(d18:1/24:0) was demonstrated to have a correlation with inflammation grades by liver biopsy in CHB patients.
Conclusions:
Serum sphingolipids have close relation with hepatic injury in chronic HBV infection, especially that SM(d18:1/24:0) might be a potential serum biomarker.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology

